Candor Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.70 Cr
- Paid Up Capital ₹ 9.10 M
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 9.28 Cr
- Satisfied Charges ₹ 1.00 Cr
- Revenue Growth -42.06%
- Profit Growth -191.81%
- Ebitda -21.12%
- Net Worth -3.16%
- Total Assets -18.25%
About Candor Biotech
Candor Biotech Limited (CBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 10 July 2002 and has a history of 22 years and seven months. Its registered office is in U T, Chandigarh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 1.70 Cr and a paid-up capital of Rs 9.10 M.
The company currently has active open charges totaling ₹9.28 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amarjit Singh, Maninder Kaur, and Surinder Singh serve as directors at the Company.
Company Details
-
LocationU T, Chandigarh
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232CH2002PLC025265
-
Company No.
025265
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
10 Jul 2002
-
Date of AGM
30 Sep 2015
-
Date of Balance Sheet
31 Mar 2015
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Candor Biotech Limited offer?
Candor Biotech Limited offers a wide range of products and services, including Health Conditions, Pain Relief.
Who are the key members and board of directors at Candor Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amarjit Singh
|
Managing Director | 10-Jul-2002 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Maninder Kaur
|
Director | 16-Feb-2005 | Current |
|
Surinder Singh
|
Additional Director | 14-Jun-2019 | Current |
Financial Performance of Candor Biotech.
Candor Biotech Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 42.06% decrease. The company also saw a substantial fall in profitability, with a 191.81% decrease in profit. The company's net worth dipped by a decrease of 3.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Candor Biotech?
In 2015, Candor Biotech had a promoter holding of 76.09% and a public holding of 23.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹9.28 Cr
₹1.00 Cr
Charges Breakdown by Lending Institutions
- Punjab National Bank : 9.21 Cr
- Director Of Industries Himachal Pradesh Through General Manager District Industries Centre : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jun 2014 | Punjab National Bank | ₹3.00 M | Open |
| 17 Jan 2014 | Punjab National Bank | ₹2.00 M | Open |
| 11 Jun 2013 | Punjab National Bank | ₹2.00 M | Open |
| 29 Oct 2010 | Punjab National Bank | ₹6.00 M | Open |
| 07 Aug 2008 | Director Of Industries Himachal Pradesh Through General Manager District Industries Centre | ₹0.71 M | Open |
How Many Employees Work at Candor Biotech?
Candor Biotech has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Candor Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Candor Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
